← Eichor
Study identifier: NCT06929364 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Role of Probiotics in the Treatment of Endometriosis (ProMetrioS): a Randomised Double-blinded Placebo-controlled Cross-over Trial

Condition: Endometriosis · Probiotics  ·  Sponsor: The Gut Microbiome Center (Centar za crijevni mikrobiom)

PhaseNA
Planned participants40
Who can joinFemale, N/A to 35 Years
Healthy volunteersNo

About this study

ProMetrioS is a randomised blinded placebo-controlled cross-over trial investigating the effect of specific multistrain probiotics in patients with endometriosis. The aim of this clinical trial is to determine whether probiotic treatment can significantly modulate gut microbiome composition and functionality in endometriosis patients, specifically parameters associated with the estrobolome.

This description comes directly from the study's public registry record.

Talk to the study team

Ira Renko, MS  ·  955096473  ·  ira.renko@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

University Hospital Center ZagrebZagreb, CroatiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06929364